1 Market Overview of Inflammatory Skin Diseases Drugs 1.1 Inflammatory Skin Diseases Drugs Market Overview 1.1.1 Inflammatory Skin Diseases Drugs Product Scope 1.1.2 Market Status and Outlook 1.2 Global Inflammatory Skin Diseases Drugs Market Size Overview by Region 2015 VS 2020 VS 2026 1.3 Global Inflammatory Skin Diseases Drugs Market Size by Region (2015-2026) 1.4 Global Inflammatory Skin Diseases Drugs Historic Market Size by Region (2015-2020) 1.5 Global Inflammatory Skin Diseases Drugs Market Size Forecast by Region (2021-2026) 1.6 Key Regions, Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) 1.6.1 North America Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) 1.6.2 Europe Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) 1.6.3 Asia-Pacific Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) 1.6.4 Latin America Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) 1.6.5 Middle East & Africa Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) 2 Inflammatory Skin Diseases Drugs Market Overview by Type 2.1 Global Inflammatory Skin Diseases Drugs Market Size by Type: 2015 VS 2020 VS 2026 2.2 Global Inflammatory Skin Diseases Drugs Historic Market Size by Type (2015-2020) 2.3 Global Inflammatory Skin Diseases Drugs Forecasted Market Size by Type (2021-2026) 2.4 Retinoids 2.5 Corticosteroids 2.6 Calcineurin Inhibitors 2.7 Others 3 Inflammatory Skin Diseases Drugs Market Overview by Application 3.1 Global Inflammatory Skin Diseases Drugs Market Size by Application: 2015 VS 2020 VS 2026 3.2 Global Inflammatory Skin Diseases Drugs Historic Market Size by Application (2015-2020) 3.3 Global Inflammatory Skin Diseases Drugs Forecasted Market Size by Application (2021-2026) 3.4 Hospital Pharmacies 3.5 Retail Pharmacies 3.6 Online Pharmacies 4 Global Inflammatory Skin Diseases Drugs Competition Analysis by Players 4.1 Global Inflammatory Skin Diseases Drugs Market Size by Players (2015-2020) 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inflammatory Skin Diseases Drugs as of 2019) 4.3 Date of Key Manufacturers Enter into Inflammatory Skin Diseases Drugs Market 4.4 Global Top Players Inflammatory Skin Diseases Drugs Headquarters and Area Served 4.5 Key Players Inflammatory Skin Diseases Drugs Product Solution and Service 4.6 Competitive Status 4.6.1 Inflammatory Skin Diseases Drugs Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Pfizer 5.1.1 Pfizer Profile 5.1.2 Pfizer Main Business 5.1.3 Pfizer Inflammatory Skin Diseases Drugs Products, Services and Solutions 5.1.4 Pfizer Inflammatory Skin Diseases Drugs Revenue (US$ Million) & (2015-2020) 5.1.5 Pfizer Recent Developments 5.2 Merck 5.2.1 Merck Profile 5.2.2 Merck Main Business 5.2.3 Merck Inflammatory Skin Diseases Drugs Products, Services and Solutions 5.2.4 Merck Inflammatory Skin Diseases Drugs Revenue (US$ Million) & (2015-2020) 5.2.5 Merck Recent Developments 5.3 AbbVie 5.5.1 AbbVie Profile 5.3.2 AbbVie Main Business 5.3.3 AbbVie Inflammatory Skin Diseases Drugs Products, Services and Solutions 5.3.4 AbbVie Inflammatory Skin Diseases Drugs Revenue (US$ Million) & (2015-2020) 5.3.5 Novartis Recent Developments 5.4 Novartis 5.4.1 Novartis Profile 5.4.2 Novartis Main Business 5.4.3 Novartis Inflammatory Skin Diseases Drugs Products, Services and Solutions 5.4.4 Novartis Inflammatory Skin Diseases Drugs Revenue (US$ Million) & (2015-2020) 5.4.5 Novartis Recent Developments 5.5 Boehringer Ingelheim 5.5.1 Boehringer Ingelheim Profile 5.5.2 Boehringer Ingelheim Main Business 5.5.3 Boehringer Ingelheim Inflammatory Skin Diseases Drugs Products, Services and Solutions 5.5.4 Boehringer Ingelheim Inflammatory Skin Diseases Drugs Revenue (US$ Million) & (2015-2020) 5.5.5 Boehringer Ingelheim Recent Developments 5.6 Amgen 5.6.1 Amgen Profile 5.6.2 Amgen Main Business 5.6.3 Amgen Inflammatory Skin Diseases Drugs Products, Services and Solutions 5.6.4 Amgen Inflammatory Skin Diseases Drugs Revenue (US$ Million) & (2015-2020) 5.6.5 Amgen Recent Developments 5.7 Eli Lilly 5.7.1 Eli Lilly Profile 5.7.2 Eli Lilly Main Business 5.7.3 Eli Lilly Inflammatory Skin Diseases Drugs Products, Services and Solutions 5.7.4 Eli Lilly Inflammatory Skin Diseases Drugs Revenue (US$ Million) & (2015-2020) 5.7.5 Eli Lilly Recent Developments ... 6 North America 6.1 North America Inflammatory Skin Diseases Drugs Market Size by Country 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Inflammatory Skin Diseases Drugs Market Size by Country 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Inflammatory Skin Diseases Drugs Market Size by Region 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Inflammatory Skin Diseases Drugs Market Size by Country 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Inflammatory Skin Diseases Drugs Market Size by Country 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Inflammatory Skin Diseases Drugs Market Dynamics 11.1 Industry Trends 11.2 Market Drivers 11.3 Market Challenges 11.4 Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Inflammatory Skin Diseases Drugs Market Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026 Table 2. Global Inflammatory Skin Diseases Drugs Market Size by Region (2015-2020) (US$ Million) Table 3. Global Inflammatory Skin Diseases Drugs Market Size Share by Region (2015-2020) Table 4. Global Inflammatory Skin Diseases Drugs Forecasted Market Size by Region (2021-2026) (US$ Million) Table 5. Global Inflammatory Skin Diseases Drugs Forecasted Market Size Share by Region (2021-2026) Table 6. Global Inflammatory Skin Diseases Drugs Market Size (US$ Million) by Type: 2015 VS 2020 VS 2026 Table 7. Global Inflammatory Skin Diseases Drugs Market Size by Type (2015-2020) (US$ Million) Table 8. Global Inflammatory Skin Diseases Drugs Revenue Market Share by Type (2015-2020) Table 9. Global Inflammatory Skin Diseases Drugs Forecasted Market Size by Type (2021-2026) (US$ Million) Table 10. Global Inflammatory Skin Diseases Drugs Revenue Market Share by Type (2021-2026) Table 11. Global Inflammatory Skin Diseases Drugs Market Size (US$ Million) by Application: 2015 VS 2020 VS 2026 Table 12. Global Inflammatory Skin Diseases Drugs Market Size by Application (2015-2020) (US$ Million) Table 13. Global Inflammatory Skin Diseases Drugs Revenue Market Share by Application (2015-2020) Table 14. Global Inflammatory Skin Diseases Drugs Forecasted Market Size by Application (2021-2026) (US$ Million) Table 15. Global Inflammatory Skin Diseases Drugs Revenue Market Share by Application (2021-2026) Table 16. Global Inflammatory Skin Diseases Drugs Revenue (US$ Million) by Players (2015-2020) Table 17. Global Inflammatory Skin Diseases Drugs Revenue Market Share by Players (2015-2020) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inflammatory Skin Diseases Drugs as of 2019) Table 19. Date of Key Manufacturers Enter into Inflammatory Skin Diseases Drugs Market Table 20. Global Inflammatory Skin Diseases Drugs Top Players Headquarters and Area Served Table 21. Inflammatory Skin Diseases Drugs Product Solution and Service Table 22. Global Inflammatory Skin Diseases Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Pfizer Basic Information List Table 25. Pfizer Description and Business Overview Table 26. Pfizer Inflammatory Skin Diseases Drugs Products, Services and Solutions Table 27. Revenue (Million US$) in Inflammatory Skin Diseases Drugs Business of Pfizer (2015-2020) Table 28. Pfizer Recent Developments Table 29. Merck Basic Information List Table 30. Merck Description and Business Overview Table 31. Merck Inflammatory Skin Diseases Drugs Products, Services and Solutions Table 32. Revenue (Million US$) in Inflammatory Skin Diseases Drugs Business of Merck (2015-2020) Table 33. Merck Recent Developments Table 34. AbbVie Basic Information List Table 35. AbbVie Description and Business Overview Table 36. AbbVie Inflammatory Skin Diseases Drugs Products, Services and Solutions Table 37. Revenue (Million US$) in Inflammatory Skin Diseases Drugs Business of AbbVie (2015-2020) Table 38. AbbVie Recent Developments Table 39. Novartis Basic Information List Table 40. Novartis Description and Business Overview Table 41. Novartis Inflammatory Skin Diseases Drugs Products, Services and Solutions Table 42. Revenue (Million US$) in Inflammatory Skin Diseases Drugs Business of Novartis (2015-2020) Table 43. Novartis Recent Developments Table 44. Boehringer Ingelheim Basic Information List Table 45. Boehringer Ingelheim Description and Business Overview Table 46. Boehringer Ingelheim Inflammatory Skin Diseases Drugs Products, Services and Solutions Table 47. Revenue (Million US$) in Inflammatory Skin Diseases Drugs Business of Boehringer Ingelheim (2015-2020) Table 48. Boehringer Ingelheim Recent Developments Table 49. Amgen Basic Information List Table 50. Amgen Description and Business Overview Table 51. Amgen Inflammatory Skin Diseases Drugs Products, Services and Solutions Table 52. Revenue (Million US$) in Inflammatory Skin Diseases Drugs Business of Amgen (2015-2020) Table 53. Amgen Recent Developments Table 54. Eli Lilly Basic Information List Table 55. Eli Lilly Description and Business Overview Table 56. Eli Lilly Inflammatory Skin Diseases Drugs Products, Services and Solutions Table 57. Revenue (Million US$) in Inflammatory Skin Diseases Drugs Business of Eli Lilly (2015-2020) Table 58. Eli Lilly Recent Developments Table 59. North America Inflammatory Skin Diseases Drugs Market Size by Country (2015-2020) & (US$ Million) Table 60. North America Inflammatory Skin Diseases Drugs Market Size Share by Country (2015-2020) Table 61. Europe Inflammatory Skin Diseases Drugs Market Size by Country (2015-2020) & (US$ Million) Table 62. Europe Inflammatory Skin Diseases Drugs Market Size Share by Country (2015-2020) Table 63. Asia-Pacific Inflammatory Skin Diseases Drugs Market Size by Region (2015-2020) & (US$ Million) Table 64. Asia-Pacific Inflammatory Skin Diseases Drugs Market Size Share by Region (2015-2020) (US$ Million) Table 65. Latin America Inflammatory Skin Diseases Drugs Market Size by Country (2015-2020) & (US$ Million) Table 66. Latin America Inflammatory Skin Diseases Drugs Market Size Share by Country (2015-2020) (US$ Million) Table 67. Middle East & Africa Inflammatory Skin Diseases Drugs Market Size by Players (2015-2020) (US$ Million) Table 68. Middle East & Africa Inflammatory Skin Diseases Drugs Market Size Share by Players (2015-2020) (US$ Million) Table 69. Inflammatory Skin Diseases Drugs Market Trends Table 70. Inflammatory Skin Diseases Drugs Market Drivers Table 71. Inflammatory Skin Diseases Drugs Market Challenges Table 72. Inflammatory Skin Diseases Drugs Market Restriants Table 73. Research Programs/Design for This Report Table 74. Key Data Information from Secondary Sources Table 75. Key Data Information from Primary Sources List of Figures Figure 1. Global Inflammatory Skin Diseases Drugs Market Size Year-over-Year 2015-2026 & (US$ Million) Figure 2. Global Inflammatory Skin Diseases Drugs Market Size (US$ Million), 2015 VS 2020VS 2026 Figure 3. Global Inflammatory Skin Diseases Drugs Market Share by Regions: 2020 VS 2026 Figure 4. North America Inflammatory Skin Diseases Drugs Market Size (US$ Million) Growth Rate (2015-2026) Figure 5. Europe Inflammatory Skin Diseases Drugs Market Size (US$ Million) and Growth Rate (2015-2026) Figure 6. Asia-Pacific Inflammatory Skin Diseases Drugs Market Size (US$ Million) and Growth Rate (2015-2026) Figure 7. Latin America Inflammatory Skin Diseases Drugs Market Size (US$ Million) and Growth Rate (2015-2026) Figure 8. Middle East & Africa Inflammatory Skin Diseases Drugs Market Size (US$ Million) and Growth Rate (2015-2026) Figure 9. Global Inflammatory Skin Diseases Drugs Market Share by Type in 2020 & 2026 Figure 10. Retinoids Market Size (US$ Million) YoY Growth (2015-2026) Figure 11. Corticosteroids Market Size (US$ Million) YoY Growth (2015-2026) Figure 12. Calcineurin Inhibitors Market Size (US$ Million) YoY Growth (2015-2026) Figure 13. Others Market Size (US$ Million) YoY Growth (2015-2026) Figure 14. Global Inflammatory Skin Diseases Drugs Market Size Share by Application in 2020 & 2026 Figure 15. Hospital Pharmacies Market Size (US$ Million) YoY Growth (2015-2026) Figure 16. Retail Pharmacies Market Size (US$ Million) YoY Growth (2015-2026) Figure 17. Online Pharmacies Market Size (US$ Million) YoY Growth (2015-2026) Figure 18. Inflammatory Skin Diseases Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 19. Global Top 5 and Top 10 Players Inflammatory Skin Diseases Drugs Market Share in 2019 Figure 20. United States Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. Canada Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. Germany Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. France Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. U.K. Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Italy Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Russia Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Nordic Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. Rest of Europe Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. China Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. Japan Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. South Korea Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. Southeast Asia Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. India Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Australia Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Rest of Asia-Pacific Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Mexico Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Brazil Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Rest of Latin America Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Turkey Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Saudi Arabia Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. UAE Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Rest of Middle East & Africa Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 43. Bottom-up and Top-down Approaches for This Report Figure 44. Data Triangulation

Pfizer Merck AbbVie Novartis Boehringer Ingelheim Amgen Eli Lilly